Form 4: Exact Sciences CEO Kevin Conroy Reports Stock Transactions

CEO Kevin Conroy reports acquisition and disposal of Exact Sciences Corp. stock and restricted stock units.

Summary

• On February 25, 2025, Kevin Conroy, the President and CEO of Exact Sciences Corp., reported transactions involving the company's common stock.
• Conroy acquired 13,180 shares of common stock upon the vesting of restricted stock units.
• He also disposed of 6,195 shares to cover tax withholding obligations related to the vesting of these units at a price of $51.28 per share.
• Following these transactions, Conroy directly owns 1,115,183 shares of Exact Sciences common stock.
• Additionally, he indirectly owns shares through a 401(k) plan (28,566 shares) and several Grantor Retained Annuity Trusts (totaling 240,756 shares).
• Conroy also holds 770,611 vested and unvested options and restricted stock units.
• He was also granted 111,146 restricted stock units that vest in four equal annual installments beginning on February 27, 2026.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the filing primarily reflects routine stock transactions related to executive compensation. There's no indication of unusual activity or significant concern.

Positives

• The vesting of restricted stock units indicates a continued alignment of the CEO's interests with those of the shareholders.

Negatives

• The disposal of shares to cover tax obligations, while standard, slightly reduces the CEO's direct holdings.

Risks

• Significant stock ownership by executives can present risks if their decisions are overly influenced by short-term stock performance.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies and are closely monitored by investors for insights into management's confidence in the company's future prospects. Form 4 filings are a standard part of regulatory compliance.

Comparison to Industry Standards

• Executive compensation packages often include stock options and restricted stock units to align management's interests with shareholders, a practice common among companies like Guardant Health and Foundation Medicine.
• Tax withholding practices related to stock vesting are standard across the industry.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they reflect standard executive compensation practices.

Key Dates

Keywords

Exact Sciences, EXAS, Kevin Conroy, Stock Transactions, Restricted Stock Units, Form 4, Beneficial Ownership, CEO